位置:首页 > 蛋白库 > H2018_AKKM8
H2018_AKKM8
ID   H2018_AKKM8             Reviewed;         493 AA.
AC   B2UP57;
DT   02-JUN-2021, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-2008, sequence version 1.
DT   03-AUG-2022, entry version 74.
DE   RecName: Full=Beta-hexosaminidase Amuc_2018 {ECO:0000305};
DE            EC=3.2.1.52 {ECO:0000269|PubMed:29304441, ECO:0000269|PubMed:30846208};
DE   AltName: Full=Beta-N-acetylhexosaminidase Am2301 {ECO:0000303|PubMed:29304441, ECO:0000303|PubMed:30846208};
DE   Flags: Precursor;
GN   OrderedLocusNames=Amuc_2018 {ECO:0000312|EMBL:ACD05828.1};
OS   Akkermansia muciniphila (strain ATCC BAA-835 / DSM 22959 / JCM 33894 / BCRC
OS   81048 / CCUG 64013 / CIP 107961 / Muc).
OC   Bacteria; Verrucomicrobia; Verrucomicrobiae; Verrucomicrobiales;
OC   Akkermansiaceae; Akkermansia.
OX   NCBI_TaxID=349741;
RN   [1] {ECO:0000312|Proteomes:UP000001031}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC BAA-835 / DSM 22959 / JCM 33894 / BCRC 81048 / CCUG 64013 / CIP
RC   107961 / Muc;
RX   PubMed=21390229; DOI=10.1371/journal.pone.0016876;
RA   van Passel M.W., Kant R., Zoetendal E.G., Plugge C.M., Derrien M.,
RA   Malfatti S.A., Chain P.S., Woyke T., Palva A., de Vos W.M., Smidt H.;
RT   "The genome of Akkermansia muciniphila, a dedicated intestinal mucin
RT   degrader, and its use in exploring intestinal metagenomes.";
RL   PLoS ONE 6:E16876-E16876(2011).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, BIOPHYSICOCHEMICAL
RP   PROPERTIES, AND SUBSTRATE SPECIFICITY.
RC   STRAIN=ATCC BAA-835 / DSM 22959 / JCM 33894 / BCRC 81048 / CCUG 64013 / CIP
RC   107961 / Muc {ECO:0000303|PubMed:29304441};
RX   PubMed=29304441; DOI=10.1016/j.carres.2017.12.007;
RA   Wang M., Zhang X.Y., Guo R.R., Cai Z.P., Hu X.C., Chen H., Wei S.,
RA   Voglmeir J., Liu L.;
RT   "Cloning, purification and biochemical characterization of two beta-N-
RT   acetylhexosaminidases from the mucin-degrading gut bacterium Akkermansia
RT   muciniphila.";
RL   Carbohydr. Res. 457:1-7(2018).
RN   [3] {ECO:0007744|PDB:6JE8, ECO:0007744|PDB:6JEA, ECO:0007744|PDB:6JEB}
RP   X-RAY CRYSTALLOGRAPHY (1.50 ANGSTROMS) OF 22-490 IN COMPLEXES WITH
RP   N-ACETYLGLUCOSAMINE AND ZINC, FUNCTION, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, ACTIVE SITES, AND MUTAGENESIS OF ASP-278;
RP   GLU-279 AND TYR-373.
RX   PubMed=30846208; DOI=10.1016/j.bbrc.2019.02.074;
RA   Chen X., Wang J., Liu M., Yang W., Wang Y., Tang R., Zhang M.;
RT   "Crystallographic evidence for substrate-assisted catalysis of beta-N-
RT   acetylhexosaminidas from Akkermansia muciniphila.";
RL   Biochem. Biophys. Res. Commun. 511:833-839(2019).
CC   -!- FUNCTION: Hydrolyzes terminal GlcNAc residues from terminally
CC       unbranched N-glycans and from chitobiose. Hydrolyzes beta-1,6-linked N-
CC       acetylglucosamine and beta-1,4-linked N-acetylgalactosamine from pNP-
CC       alpha-GalNAc[beta1,3Gal]beta1,6GlcNAc and pNP-beta-GlcNAc-beta1,4-
CC       GalNAc substrates, respectively, as well as beta-1,2-linked N-
CC       acetylglucosamine units from the non-reducing end of N-glycans.
CC       Hydrolyzes GlcNAc residues linked to alpha1,3- or alpha1,6-mannose
CC       branch, but has low activity on substrates with more than one GlcNAc
CC       residue on one of the mannose branches. Releases terminal GlcNAc
CC       moieties from the N-glycopeptide Gly-Glu-Asn-(GlcNAc2Man3GlcNAc2)-Arg
CC       with high efficiency. Has moderate hydrolytic activity on the
CC       chitobiose moiety of N-glycopeptide substrate Gly-Glu-Asn-(GlcNAc2)-
CC       Arg. Does not hydrolyze GlcNAc residues from N-glycan structures
CC       bearing a bisecting GlcNAc moiety (beta1,4-linked GlcNAc to the
CC       beta1,4-linked core mannose) (PubMed:29304441). Potentially capable of
CC       cleaving the specific glycoside linkages in the process of mucin
CC       degradation in human intestinal tract (Probable). Hydrolyzes synthetic
CC       substrate pNP-beta-GlcNAc with high activity and pNP-beta-GalNAc to a
CC       lesser extent (PubMed:29304441, PubMed:30846208). Does not hydrolyze
CC       pNP-beta-glucose, pNP-beta-galactose, pNP-alpha-glucose, pNP-alpha-
CC       galactose, pNP-alpha-GlcNAc or pNP-alpha-fucose (PubMed:29304441).
CC       {ECO:0000269|PubMed:29304441, ECO:0000269|PubMed:30846208,
CC       ECO:0000305}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Hydrolysis of terminal non-reducing N-acetyl-D-hexosamine
CC         residues in N-acetyl-beta-D-hexosaminides.; EC=3.2.1.52;
CC         Evidence={ECO:0000269|PubMed:29304441, ECO:0000269|PubMed:30846208};
CC   -!- ACTIVITY REGULATION: Significantly inhibited by the addition of sodium
CC       dodecyl sulfate (SDS), but not by EDTA, urea, 2-mercaptoethanol or
CC       Triton X-100. Strongly inhibited by Cu2(+) ions, in case of which the
CC       activity is decreased by 70%. No significant inhibition with Al(3+),
CC       Fe(3+), Ca(2+), Cd(2+), Mg(2+), Mn(2+), Ni(2+) and Zn(2+) ions.
CC       Strongly inhibited by PugNAc (O-(2-acetamido-2-deoxy-D-
CC       glucopyranosylideneamino) N-phenylcarbamate) in the sub-micromolar
CC       concentration range. PugNAc at a concentration of 0.5 mM decreases the
CC       activity by 50% and the addition of 1 mM PugNAc fully inhibits the
CC       enzyme. No significant reduction in the activity by alkylation using N-
CC       ethylmaleimide or 2-iodoacetamide. {ECO:0000269|PubMed:29304441}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.031 mM for pNP-beta-GlcNAc (at pH 7.0 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:30846208};
CC         KM=0.52 mM for pNP-beta-GlcNAc (at pH 5.0 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:29304441};
CC         KM=0.11 mM for pNP-beta-GalNAc (at pH 5.0 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:29304441};
CC         Vmax=79.99 umol/min/mg enzyme with pNP-beta-GlcNAc as substrate (at
CC         pH 7.0 and 37 degrees Celsius) {ECO:0000269|PubMed:30846208};
CC         Vmax=44.0 umol/min/mg enzyme with pNP-beta-GlcNAc as substrate (at pH
CC         5.0 and 37 degrees Celsius) {ECO:0000269|PubMed:29304441};
CC         Note=kcat is 1.01 sec(-1) and kcat/KM is 34.34 mM(-1)sec(-1) with
CC         pNP-beta-GlcNAc as substrate. {ECO:0000269|PubMed:30846208};
CC       pH dependence:
CC         Optimum pH is 5.0. The activity drops sharply below pH 4.5 and above
CC         pH 5.5. {ECO:0000269|PubMed:29304441};
CC       Temperature dependence:
CC         Optimum temperature is 37 degrees Celsius. Retains more than 90% of
CC         activity after 96 hours of incubation at 37 degrees Celsius and after
CC         12 hours of incubation at 42 degrees Celsius.
CC         {ECO:0000269|PubMed:29304441};
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 20 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP001071; ACD05828.1; -; Genomic_DNA.
DR   RefSeq; WP_012421042.1; NC_010655.1.
DR   PDB; 6JE8; X-ray; 1.80 A; A=22-490.
DR   PDB; 6JEA; X-ray; 2.27 A; A=22-490.
DR   PDB; 6JEB; X-ray; 1.50 A; A=22-490.
DR   PDBsum; 6JE8; -.
DR   PDBsum; 6JEA; -.
DR   PDBsum; 6JEB; -.
DR   AlphaFoldDB; B2UP57; -.
DR   SMR; B2UP57; -.
DR   STRING; 349741.Amuc_2018; -.
DR   CAZy; GH20; Glycoside Hydrolase Family 20.
DR   EnsemblBacteria; ACD05828; ACD05828; Amuc_2018.
DR   KEGG; amu:Amuc_2018; -.
DR   eggNOG; COG3525; Bacteria.
DR   HOGENOM; CLU_007082_5_1_0; -.
DR   OrthoDB; 727559at2; -.
DR   BioCyc; AMUC349741:G1GBX-2149-MON; -.
DR   Proteomes; UP000001031; Chromosome.
DR   GO; GO:0032428; F:beta-N-acetylgalactosaminidase activity; IDA:UniProtKB.
DR   GO; GO:0016231; F:beta-N-acetylglucosaminidase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0102148; F:N-acetyl-beta-D-galactosaminidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0052781; P:chitobiose catabolic process; IDA:UniProtKB.
DR   GO; GO:0000272; P:polysaccharide catabolic process; IDA:UniProtKB.
DR   Gene3D; 3.30.379.10; -; 1.
DR   InterPro; IPR025705; Beta_hexosaminidase_sua/sub.
DR   InterPro; IPR015883; Glyco_hydro_20_cat.
DR   InterPro; IPR017853; Glycoside_hydrolase_SF.
DR   InterPro; IPR029018; Hex-like_dom2.
DR   InterPro; IPR015882; HEX_bac_N.
DR   PANTHER; PTHR22600; PTHR22600; 1.
DR   Pfam; PF00728; Glyco_hydro_20; 1.
DR   Pfam; PF02838; Glyco_hydro_20b; 1.
DR   PIRSF; PIRSF001093; B-hxosamndse_ab_euk; 1.
DR   PRINTS; PR00738; GLHYDRLASE20.
DR   SUPFAM; SSF51445; SSF51445; 1.
DR   SUPFAM; SSF55545; SSF55545; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Carbohydrate metabolism; Glycosidase; Hydrolase;
KW   Metal-binding; Polysaccharide degradation; Reference proteome; Signal;
KW   Zinc.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000255"
FT   CHAIN           22..493
FT                   /note="Beta-hexosaminidase Amuc_2018"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000452893"
FT   ACT_SITE        151
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000305|PubMed:30846208,
FT                   ECO:0007744|PDB:6JE8, ECO:0007744|PDB:6JEA,
FT                   ECO:0007744|PDB:6JEB"
FT   ACT_SITE        214
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000305|PubMed:30846208,
FT                   ECO:0007744|PDB:6JE8, ECO:0007744|PDB:6JEA,
FT                   ECO:0007744|PDB:6JEB"
FT   ACT_SITE        279
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000269|PubMed:30846208,
FT                   ECO:0007744|PDB:6JEB"
FT   BINDING         122
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:30846208,
FT                   ECO:0007744|PDB:6JEA"
FT   BINDING         227
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:30846208,
FT                   ECO:0007744|PDB:6JE8, ECO:0007744|PDB:6JEA,
FT                   ECO:0007744|PDB:6JEB"
FT   BINDING         247
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:30846208,
FT                   ECO:0007744|PDB:6JE8, ECO:0007744|PDB:6JEA,
FT                   ECO:0007744|PDB:6JEB"
FT   BINDING         278
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:30846208,
FT                   ECO:0007744|PDB:6JEA"
FT   BINDING         288
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:30846208,
FT                   ECO:0007744|PDB:6JE8, ECO:0007744|PDB:6JEA,
FT                   ECO:0007744|PDB:6JEB"
FT   BINDING         291
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:30846208,
FT                   ECO:0007744|PDB:6JE8, ECO:0007744|PDB:6JEA,
FT                   ECO:0007744|PDB:6JEB"
FT   BINDING         345
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:30846208,
FT                   ECO:0007744|PDB:6JEA"
FT   BINDING         373..375
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:30846208,
FT                   ECO:0007744|PDB:6JEA"
FT   BINDING         421..423
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:30846208,
FT                   ECO:0007744|PDB:6JEA"
FT   MUTAGEN         278
FT                   /note="D->A: No significant change in KM value, but 37-fold
FT                   and 2600-fold decrease in specific activity and kcat/KM
FT                   value compared to that of wild-type, respectively."
FT                   /evidence="ECO:0000269|PubMed:30846208"
FT   MUTAGEN         279
FT                   /note="E->A: No significant change in KM value, but 8.7-
FT                   fold and 3500-fold decrease in specific activity and
FT                   kcat/KM value compared to that of wild-type, respectively."
FT                   /evidence="ECO:0000269|PubMed:30846208"
FT   MUTAGEN         373
FT                   /note="Y->F: No significant change in KM value, but 6.3-
FT                   fold and 1226-fold decrease in specific activity and
FT                   kcat/KM value compared to that of wild-type, respectively."
FT                   /evidence="ECO:0000269|PubMed:30846208"
FT   STRAND          32..42
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   STRAND          46..51
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   STRAND          60..65
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   STRAND          68..75
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   HELIX           76..94
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   STRAND          100..107
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   STRAND          112..118
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   TURN            120..122
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   HELIX           127..139
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   STRAND          144..148
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   HELIX           164..167
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   TURN            168..170
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   STRAND          171..173
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   HELIX           188..199
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   TURN            200..202
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   STRAND          204..208
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   STRAND          212..214
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   HELIX           216..221
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   HELIX           223..225
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   STRAND          226..228
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   HELIX           251..267
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   STRAND          272..274
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   HELIX           283..287
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   HELIX           289..298
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   HELIX           303..320
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   STRAND          324..328
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   HELIX           333..335
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   STRAND          341..344
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   HELIX           350..360
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   STRAND          363..366
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   TURN            369..371
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   TURN            385..387
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   HELIX           393..397
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   TURN            401..404
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   HELIX           407..410
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   STRAND          413..420
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   HELIX           428..435
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   HELIX           438..447
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   HELIX           450..452
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   HELIX           455..473
FT                   /evidence="ECO:0007829|PDB:6JEB"
FT   HELIX           481..483
FT                   /evidence="ECO:0007829|PDB:6JEB"
SQ   SEQUENCE   493 AA;  56044 MW;  5EC0C54715B8946C CRC64;
     MARPLPILGG ILLSFSPPAE ATAQYSIIPE PSRTELRQET AKTLQLLSDQ EVPTLETDAY
     RLTVTPQGAH LASGGREGRI YGLATLRQLR DQLAGQPEGI PCGVITDKPR YPWRGLMVDP
     ARHFIPAADL KKFVDMMAYY KFNRLHLHLT DNQGWRLPVP GYPKLKSVAS RREESFGDGI
     PHEGMYTKQE LKELVAYCAA RGIDVIPEID MPGHNQALHA AYPEFFCFPK PDMNVRTTAG
     NSKELVCPQK PEVWKFYASV FNELKDIFPS GIVHLGGDEA PTELWEKCPL CREARTRAAM
     KDEQEQMKAF FAKTAALLAK NGQTPQFWYE GNAGIYHPGE TVYAWRQGQA LQSIEKTKKA
     GLNLIMASSE YCYLDFPQIQ GQRNWGWMKT TTLQKCYDLD PAFGKPEKEA GHIRGVHAPV
     WAERLPDLNH LLYRAYPRAC AIAEAGWSPM GVRSWENFRR KLADHRQFIL KRFNYDMERT
     QGNEPAFRWE NNK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024